Cargando…
Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson’s Disease
Alpha-synuclein deposits are detectable in skin biopsies of patients with Parkinson’s disease and other synucleinopathies like multiple system atrophy by immunohistochemical staining. As they are easily to obtain, they appear a promising tool for the pre-mortem histopathological confirmation of the...
Autor principal: | Doppler, Kathrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461714/ https://www.ncbi.nlm.nih.gov/pubmed/33814464 http://dx.doi.org/10.3233/JPD-202489 |
Ejemplares similares
-
Dermal Phospho-Alpha-Synuclein Deposition in Patients With Parkinson's Disease and Mutation of the Glucocerebrosidase Gene
por: Doppler, Kathrin, et al.
Publicado: (2018) -
Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson’s disease
por: Doppler, Kathrin, et al.
Publicado: (2017) -
Skin alpha-synuclein deposit patterns: A predictor of Parkinson's disease subtypes
por: Han, Yihang, et al.
Publicado: (2022) -
The Role of Alpha-Synuclein Deposits in Parkinson’s Disease: A Focus on the Human Retina
por: Di Pippo, Mariachiara, et al.
Publicado: (2023) -
Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson’s Disease
por: Fricova, Dominika, et al.
Publicado: (2020)